Carstensen, Saskia
Gress, Christina
Erpenbeck, Veit J.
Kazani, Shamsah D.
Hohlfeld, Jens M.
Sandham, David A.
Müller, Meike http://orcid.org/0000-0002-7586-356X
Funding for this research was provided by:
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Article History
Received: 31 May 2021
Accepted: 27 September 2021
First Online: 7 October 2021
Declarations
:
: The study was approved by the Ethics Committee of the Hannover Medical School (7882_BO_S_2018). All subjects gave written informed consent.
: Not applicable.
: SC’s, CG’s, JMH’s and MM’s institution received funding from ALK, Allergopharma, Astellas, AstraZeneca, GlaxoSmithKline, Janssen Pharmaceutica NV, LETI, Novartis, and Sanofi-Aventis for clinical trial conduct outside the submitted work. JMH reports personal fees from Boehringer Ingelheim, CSL Behring, HAL, Merck, and Novartis for consultancy and lectures outside the submitted work. VJE and SK were employees of Novartis at the time of the study. DAS is an employee of Novartis.